Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (380)	3/1/2013 12:55:25 PM
From: ghmm	Respond to of 507

Congrats on CLDX. I thought I missed it in the 6-7 range so never looked more closely then and so I'm on the sidelines on this one. Hope does well for you! I also like that NKTR has a lot going for them. I am more of a partner person rather than a go-it-alone no matter how much HR plays up the pain I would prefer partnering they certainly aren't in a position to take a pain drug to market themselves. I was rushed for time didn't get a close listen but things I heard seems we have several newsworthy things across multiple programs.